{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T16:37:00Z","timestamp":1793205420797,"version":"4.5.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,11]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To describe the rate and 30-day outcomes after gender affirmation surgery in transgender men.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>\n                      We conducted a cross-sectional population-based study. Patients with male gender who underwent hysterectomy for benign indications between 2013 and 2016 in the American College of Surgeons\u2019 National Surgical Quality Improvement database were identified. Propensity score matching was performed to ameliorate selection bias. Student\n                      <jats:italic toggle=\"yes\">t<\/jats:italic>\n                      test and Mann-Whitney tests were used to compare continuous variables between two groups where appropriate. The \u03c7\n                      <jats:sup>2<\/jats:sup>\n                      and Fisher exact tests were used where appropriate to compare categorical variables across groups. Logistic regression models were used to evaluate factors associated with any postoperative adverse event.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      Of 159,736 hysterectomies performed during the study period, 521 (0.3%) were performed in transgender men. The mean age was 23.9\u00b113.8 years, and the median body mass index was 29.0 (range 24.8\u201334.2). The majority of patients were white (64.5%). The most common specified diagnosis associated with hysterectomy was gender identity disorder (20.9%). Laparoscopy was the most common route (57.2%) followed by laparoscopic-assisted vaginal hysterectomy (20.0%) and abdominal hysterectomy (15.2%). After propensity matching was performed, the composite rate of postoperative complications was similar between the transgender male and control groups (3.4% vs 3.3%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =.92). On multivariate logistic regression controlling for age, presence of a major medical comorbidity, and primary mode of surgery, transgender male status and presence of a major medical comorbidity were not significantly associated with complications (adjusted odds ratio [OR] 1.11, 95% CI 0.56\u20132.10 and adjusted OR 1.16, 95% CI 0.58\u20132.27, respectively). Age remained weakly associated with postoperative complications (adjusted OR 1.04, 95% CI 1.01\u20131.06), whereas minimally invasive approaches to hysterectomy were significantly associated with lower incidences of complications (vaginal, adjusted OR 0.04, 95% CI 0.002\u20130.17; laparoscopic adjusted OR 0.09, 95% CI 0.04\u20130.18; and laparoscopic-assisted vaginal hysterectomy, adjusted OR 0.07, 95% CI 0.02\u20130.20).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Less than 1% of hysterectomies performed annually are for transgender male patients. Postoperative complications after hysterectomy in this patient population are similar to the complication rates found in cisgender women.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000002936","type":"journal-article","created":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T21:04:56Z","timestamp":1539119096000},"page":"1265-1273","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":70,"title":["Complication Rates and Outcomes After Hysterectomy in Transgender Men"],"prefix":"10.1097","volume":"132","author":[{"given":"C. Emi","family":"Bretschneider","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sheyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Pollard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile A.","family":"Ferrando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261028","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.2105\/AJPH.2016.303578","article-title":"Transgender population size in the United States: a meta-regression of population-based probability samples","volume":"107","author":"Meerwijk","year":"2017","journal-title":"Am J Public Health"},{"key":"R2-20261028","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1365-2265.2009.03625.x","article-title":"Hormonal therapy and sex reassignment: a systematic review and meta-analysis of quality of life and psychosocial outcomes","volume":"72","author":"Murad","year":"2010","journal-title":"Clin Endocrinol"},{"key":"R3-20261028","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1210\/jc.2016-1276","article-title":"Cross-sex hormone treatment and psychobiological changes in transsexual persons: two-year follow-up data","volume":"101","author":"Fisher","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"R5-20261028","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1210\/jc.2009-0345","article-title":"Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline","volume":"94","author":"Hembree","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R6-20261028","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/15532730903008065","article-title":"World Professional Association for Transgender Health's standards of care requirements of hormone therapy for adults with gender identity disorder","volume":"11","author":"Meyer","year":"2009","journal-title":"Int J Transgend"},{"key":"R7-20261028","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1055\/s-0030-1267241","article-title":"Vaginal hysterectomy and bilateral adnexectomy for female to male transsexuals in an interdisciplinary concept [in German]","volume":"43","author":"Kaiser","year":"2011","journal-title":"Handchir Mikrochir Plast Chir"},{"key":"R8-20261028","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/AOG.0000000000001866","article-title":"Feasibility of vaginal hysterectomy for female-to-male transgender men","volume":"129","author":"Obedin-Maliver","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R9-20261028","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1097\/01.AOG.0000286778.44943.5a","article-title":"Total laparoscopic hysterectomy for female-to-male transsexuals","volume":"110","author":"O\u2019Hanlan","year":"2007","journal-title":"Obstet Gynecol"},{"key":"R10-20261028","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0301-2115(99)00091-3","article-title":"Vaginectomy and laparoscopically assisted vaginal hysterectomy as adjunctive surgery for female-to-male transsexual reassignment: preliminary report","volume":"87","author":"Ergeneli","year":"1999","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R11-20261028","article-title":"Hysterectomy for the transgendered male: a review of perioperative considerations and surgical techniques with description of a novel 2-port laparoscopic approach","author":"Marfori","year":"2017","journal-title":"J Minim Invasive Gynecol"},{"key":"R12-20261028","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/AOG.0b013e31822dac5d","article-title":"Postoperative complications after gynecologic surgery","volume":"118","author":"Erekson","year":"2011","journal-title":"Obstet Gynecol"},{"key":"R13-20261028","doi-asserted-by":"crossref","first-page":"344.e1","DOI":"10.1016\/j.ajog.2015.05.014","article-title":"Predictors of 30-day readmission and impact of same-day discharge in laparoscopic hysterectomy","volume":"213","author":"Jennings","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"R14-20261028","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jmig.2017.10.013","article-title":"Readmission rates after same-day discharge compared with postoperative day 1 discharge after benign laparoscopic hysterectomy","volume":"25","author":"Sheyn","year":"2018","journal-title":"J Minim Invasive Gynecol"},{"key":"R15-20261028","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/aogs.13270","article-title":"Trends in readmission rate by route of hysterectomy\u2014a single-center experience","volume":"97","author":"Kreuninger","year":"2018","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R17-20261028","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/AOG.0b013e318299a6cf","article-title":"Nationwide trends in the performance of inpatient hysterectomy in the United States","volume":"122","author":"Wright","year":"2013","journal-title":"Obstet Gynecol"},{"key":"R18-20261028","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.annepidem.2007.10.011","article-title":"Risk estimates of hysterectomy and selected conditions commonly treated with hysterectomy","volume":"18","author":"Merrill","year":"2008","journal-title":"Ann Epidemiol"},{"key":"R19-20261028","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3324\/haematol.2009.008417","article-title":"Hematocrit and risk of venous thromboembolism in a general population. The Tromso study","volume":"95","author":"Braekkan","year":"2010","journal-title":"Haematologica"},{"key":"R20-20261028","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.metabol.2014.05.005","article-title":"Testosterone therapy, thrombosis, thrombophilia, cardiovascular events","volume":"63","author":"Glueck","year":"2014","journal-title":"Metabolism"},{"key":"R21-20261028","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1210\/jc.2011-2591","article-title":"Testosterone treatment and mortality in men with low testosterone levels","volume":"97","author":"Shores","year":"2012","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006250-201811000-00024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T16:01:30Z","timestamp":1793203290000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006250-201811000-00024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000002936","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"2018-05-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}